• EUGIASHORT – series: from P3C to P5B0289X; from P5C0196X to P5C0197X; from P5C0304X to P5C0307X; from P5C0796X to P5C0798X; from P5D0049X to P5D0051X; from P5D0146X to P5D0148X; from P5E0261X to P5E0262X; from P5F0158X to P5F0161X; N3F0260RX; N3F0266RX; N3F0267RX; P5C0201X; P5D0538X; P5E0680X; P5E0682X; P5E0686X; P5E0760X; P5E0762X; P5E0765X
• EUGIAUSTND – series from P3C to P5B0521X; from P5D0410X to P5D0411X; from P5D0823X to P5D0829X; from P5E0080X to P5E0082X; from P5E0317X to P5E0320X; from P5E0322X to P5E0324X; from P5F0001X to P5F0002X; P5C0239X; P5C0241X; P5C0508X; P5C0510X; P5C0512X; P5C0597X; P5C0599X; P5C0601X; P5C0603X; P5C0684X; P5C0803X; P5C0805X; P5C0807X; 5PD0067X; 5PD0069X; 5PD0073X; 5PD0170X; 5PD0413X; 5PD0415X; 5PD0417X; 5PD0419X; 5PD0447X; 5PD0623X; 5PD0624X; 5PD0626X; 5PD0628X; 5PD0630X; 5PE0525X; 5PF0004X; 5PF0006X; 5PF0008X; 5PF0010X; 5PF0014X; 5PF0017X; 5PF0019X; 5PF0021X; 5PF0213X; 5PF0217X
• EGIAUXL – series from P3C to P5B0454X; from P5C0152X to P5E0450X; P5B0468X
“If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.